SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Sodium patents expire, and what generic alternatives are available?
Sodium is a drug marketed by Fresenius Kabi Usa, Milla Pharms, Hikma, Hospira, Hexcel, Exela Pharma, Intl Medication Sys, Nivagen Pharms Inc, Omnivium Pharms, Steriscience, Abbott, Ivax Sub Teva Pharms, Lannett, Marshall Pharma, B Braun, Baxter Hlthcare, Icu Medical Inc, Miles, Medefil Inc, Nexus Pharms, Spectra Mdcl Devices, Fresenius Medcl, Haemonetics, Laboratorios Grifols, Liebel-flarsheim, Jubilant Cadista, Nephron, Taro, Abraxis Pharm, Curium, West-ward Pharms Int, Nih Nci Dctd, 3d Imaging Drug, Bamf, Biomedcl Res Fdn, Cardinal Health 414, Decatur, Essential Isotopes, Hot Shots Nm Llc, Jubilant Draximage, Kreitchman Pet Ctr, Mcprf, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Nukemed, Petnet, Precision Nuclear, Shertech Labs Llc, Sofie, The Feinstein Inst, Ucsf Rodiopharm, Uihc Pet Imaging, Univ Tx Md Anderson, Univ Utah Cyclotron, Cardinal Health 418, Ge Healthcare, CIS, Jubilant, Intl Isotopes, Hope Pharms, Amneal, Amphastar Pharms Inc, Avet Lifesciences, Be Pharms, Caplin, Chartwell Rx, Cipla, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Hainan Poly Pharm, Micro Labs, Mylan, Mylan Labs Ltd, Nexus, Sagent Pharms Inc, Somerset Theraps Llc, Sun Pharm, Teva Parenteral, Xiromed, Hainan Poly, Anabolic, Elkins Sinn, Everylife, Halsey, Parke Davis, Perrigo, Purepac Pharm, Valeant Pharm Intl, Watson Labs, Wyeth Ayerst, Nexgen Pharma Inc, Mallinckrodt, Pharmalucence, Ailex Pharms Llc, Maia Pharms Inc, Navinta Llc, Par Pharm, Sigmapharm Labs Llc, Alvogen, Glenmark Pharms Ltd, Hetero Labs Ltd V, Belcher, Citrusphrma, Cmp Pharma Inc, Nuvo Pharms Inc, Pai Holdings Pharm, Upsher Smith Labs, Ani Pharms, Morton Grove, Roxane, Sorin, Schering, Sola Barnes Hind, Alkem Labs Ltd, Novel Labs Inc, Strides Pharma, and Us Army. and is included in two hundred and six NDAs. There are seven patents protecting this drug.
The generic ingredient in SODIUM is sodium thiosulfate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium thiosulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sodium
A generic version of SODIUM was approved as sodium thiosulfate by HOPE PHARMS on February 14th, 2012.
Summary for SODIUM
| US Patents: | 0 |
| Applicants: | 119 |
| NDAs: | 206 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for SODIUM |
| Drug Sales Revenues: | Drug sales revenues for SODIUM |
| DailyMed Link: | SODIUM at DailyMed |
US Patents and Regulatory Information for SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | sodium chloride | INJECTABLE;INJECTION | 019635-002 | Mar 9, 1988 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Pharmalucence | SODIUM PERTECHNETATE TC 99M | technetium tc-99m sodium pertechnetate | SOLUTION;INJECTION, ORAL | 017321-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Icu Medical Inc | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | sodium chloride | SOLUTION;INJECTION | 019217-003 | Nov 18, 1998 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Fresenius Kabi Usa | SODIUM PHOSPHATES | sodium phosphate, dibasic, heptahydrate; sodium phosphate, monobasic, anhydrous | INJECTABLE;INJECTION | 209997-001 | Mar 30, 2022 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
